US equities
|
MU
$934.27
▲+0.00%
INTC
$92.07
▲+0.00%
SNDK
$1,330.05
▲+0.00%
NVDA
$213.66
▲+0.00%
AAPL
$348.91
▲+0.00%
SKHY
$162.09
▲+0.00%
AMZN
$243.79
▲+0.00%
AMD
$566.42
▲+0.00%
MU
$934.27
▲+0.00%
INTC
$92.07
▲+0.00%
SNDK
$1,330.05
▲+0.00%
NVDA
$213.66
▲+0.00%
AAPL
$348.91
▲+0.00%
SKHY
$162.09
▲+0.00%
AMZN
$243.79
▲+0.00%
AMD
$566.42
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Aeglea BioTherapeutics, Inc. - Common Stock
(NQ:
AGLE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 27, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Aeglea BioTherapeutics, Inc. - Common Stock
Aeglea BioTherapeutics Inc. (NASDAQ: AGLE) Leading the Way in Friday Trading Based on Percentage Gain
September 08, 2023
Via
Investor Brand Network
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs
June 22, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:POAI),(NASDAQ:AGLE),(NASDAQ:TALS),(NASDAQ:MRTX) EQNX::TICKER_END
Via
FinancialNewsMedia